176 related articles for article (PubMed ID: 34357047)
1. Exploring the Ability of LARS2 Carboxy-Terminal Domain in Rescuing the MELAS Phenotype.
Capriglia F; Rizzo F; Petrosillo G; Morea V; d'Amati G; Cantatore P; Roberti M; Loguercio Polosa P; Bruni F
Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357047
[TBL] [Abstract][Full Text] [Related]
2. Short peptides from leucyl-tRNA synthetase rescue disease-causing mitochondrial tRNA point mutations.
Perli E; Fiorillo A; Giordano C; Pisano A; Montanari A; Grazioli P; Campese AF; Di Micco P; Tuppen HA; Genovese I; Poser E; Preziuso C; Taylor RW; Morea V; Colotti G; d'Amati G
Hum Mol Genet; 2016 Mar; 25(5):903-15. PubMed ID: 26721932
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.
Munakata K; Iwamoto K; Bundo M; Kato T
Biol Psychiatry; 2005 Mar; 57(5):525-32. PubMed ID: 15737668
[TBL] [Abstract][Full Text] [Related]
4. The phenotypic expression of mitochondrial tRNA-mutations can be modulated by either mitochondrial leucyl-tRNA synthetase or the C-terminal domain thereof.
Giordano C; Morea V; Perli E; d'Amati G
Front Genet; 2015; 6():113. PubMed ID: 25852750
[TBL] [Abstract][Full Text] [Related]
5. Molecular Investigation of Mitochondrial RNA19 Role in the Pathogenesis of MELAS Disease.
Loguercio Polosa P; Capriglia F; Bruni F
Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763267
[TBL] [Abstract][Full Text] [Related]
6. Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes.
Li R; Guan MX
Mol Cell Biol; 2010 May; 30(9):2147-54. PubMed ID: 20194621
[TBL] [Abstract][Full Text] [Related]
7. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria.
Karicheva OZ; Kolesnikova OA; Schirtz T; Vysokikh MY; Mager-Heckel AM; Lombès A; Boucheham A; Krasheninnikov IA; Martin RP; Entelis N; Tarassov I
Nucleic Acids Res; 2011 Oct; 39(18):8173-86. PubMed ID: 21724600
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology of MELAS and L-arginine effects.
Koga Y; Povalko N; Nishioka J; Katayama K; Yatsuga S; Matsuishi T
Biochim Biophys Acta; 2012 May; 1820(5):608-14. PubMed ID: 21944974
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial haplotype mutation alleviates respiratory defect of MELAS by restoring taurine modification in tRNA with 3243A > G mutation.
Ueda S; Yagi M; Tomoda E; Matsumoto S; Ueyanagi Y; Do Y; Setoyama D; Matsushima Y; Nagao A; Suzuki T; Ide T; Mori Y; Oyama N; Kang D; Uchiumi T
Nucleic Acids Res; 2023 Aug; 51(14):7480-7495. PubMed ID: 37439353
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cybrids harboring MELAS mutations in the mitochondrial tRNA(Leu(UUR)) gene.
Koga Y; Davidson M; Schon EA; King MP
Muscle Nerve Suppl; 1995; 3():S119-23. PubMed ID: 7603512
[TBL] [Abstract][Full Text] [Related]
11. mt tRFs, New Players in MELAS Disease.
Meseguer S; Rubio MP
Front Physiol; 2022; 13():800171. PubMed ID: 35273517
[TBL] [Abstract][Full Text] [Related]
12. The isolated carboxy-terminal domain of human mitochondrial leucyl-tRNA synthetase rescues the pathological phenotype of mitochondrial tRNA mutations in human cells.
Perli E; Giordano C; Pisano A; Montanari A; Campese AF; Reyes A; Ghezzi D; Nasca A; Tuppen HA; Orlandi M; Di Micco P; Poser E; Taylor RW; Colotti G; Francisci S; Morea V; Frontali L; Zeviani M; d'Amati G
EMBO Mol Med; 2014 Feb; 6(2):169-82. PubMed ID: 24413190
[TBL] [Abstract][Full Text] [Related]
13. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes.
Chomyn A; Enriquez JA; Micol V; Fernandez-Silva P; Attardi G
J Biol Chem; 2000 Jun; 275(25):19198-209. PubMed ID: 10858457
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Transfer of Wharton's Jelly Mesenchymal Stem Cells Eliminates Mutation Burden and Rescues Mitochondrial Bioenergetics in Rotenone-Stressed MELAS Fibroblasts.
Lin TK; Chen SD; Chuang YC; Lan MY; Chuang JH; Wang PW; Hsu TY; Wang FS; Tsai MH; Huang ST; Wang XW; Tsai PC; Lin HY; Liou CW
Oxid Med Cell Longev; 2019; 2019():9537504. PubMed ID: 31249652
[TBL] [Abstract][Full Text] [Related]
15. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
[TBL] [Abstract][Full Text] [Related]
16. The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation.
Park H; Davidson E; King MP
Biochemistry; 2003 Feb; 42(4):958-64. PubMed ID: 12549915
[TBL] [Abstract][Full Text] [Related]
17. The yeast model suggests the use of short peptides derived from mt LeuRS for the therapy of diseases due to mutations in several mt tRNAs.
Di Micco P; Fazzi D'Orsi M; Morea V; Frontali L; Francisci S; Montanari A
Biochim Biophys Acta; 2014 Dec; 1843(12):3065-74. PubMed ID: 25261707
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel Variant in
Xu M; Kopajtich R; Elstner M; Wang Z; Liu Z; Wang J; Prokisch H; Fang F
Front Genet; 2021; 12():638749. PubMed ID: 34054915
[TBL] [Abstract][Full Text] [Related]
19. The ROS-sensitive microRNA-9/9* controls the expression of mitochondrial tRNA-modifying enzymes and is involved in the molecular mechanism of MELAS syndrome.
Meseguer S; Martínez-Zamora A; García-Arumí E; Andreu AL; Armengod ME
Hum Mol Genet; 2015 Jan; 24(1):167-84. PubMed ID: 25149473
[TBL] [Abstract][Full Text] [Related]
20. Reduction of mitochondrial tRNALeu(UUR) aminoacylation by some MELAS-associated mutations.
Hao R; Yao YN; Zheng YG; Xu MG; Wang ED
FEBS Lett; 2004 Dec; 578(1-2):135-9. PubMed ID: 15581630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
